No-udca Uses, Dosage, Side Effects and more
No-udca is under investigation in clinical trial NCT00414869 (Preliminary Efficacy and Tolerability of No-udca After Repeated Oral Doses in Patients With Elevated Portal Pressure).
| Attribute | Details |
|---|---|
| Trade Name | No-udca |
| Generic | NCX-1000 |
| NCX-1000 Other Names | ,no-udca, no-UDCA, No-ursodeoxycholic acid |
| Type | |
| Formula | C38H55NO10 |
| Weight | Average: 685.855 Monoisotopic: 685.382596975 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
